GRCE Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Grace Therapeutics, Inc (GRCE) is not a strong buy for a beginner, long-term investor at this time. The technical indicators show a bullish trend, but the lack of significant positive catalysts, weak financial performance, and absence of proprietary trading signals suggest holding off on investment until more favorable conditions arise.
The MACD is positive and expanding, indicating bullish momentum. The RSI is neutral at 76.83, and the moving averages are bullish (SMA_5 > SMA_20 > SMA_200). Key support and resistance levels are Pivot: 4.714, R1: 5.043, S1: 4.385, R2: 5.245, S2: 4.183. However, the stock's recent candlestick pattern analysis suggests a 40% chance of a minor gain (1.34%) in the next day but potential losses in the next week (-0.9%) and month (-7.22%).
Bullish technical indicators and strong bullish sentiment in options data.
No recent news or significant trading trends from hedge funds or insiders. Weak financial performance with declining net income (-44.28% YoY) and EPS (-61.11% YoY). No recent congress trading data or analyst ratings available.
In Q3 2026, revenue remained at 0 with no growth. Net income dropped significantly to -$2,315,000 (-44.28% YoY), and EPS decreased to -0.14 (-61.11% YoY). Gross margin remained at 0 with no improvement.
No recent analyst ratings or price target changes available.
